First human test for new Alzheimer's drug begins
Disease control
Completed
This was the first study in people to test the safety and side effects of a new drug called IBC-Ab002 for early Alzheimer's disease. The study involved 40 participants who received either the drug or a placebo through an IV. The main goal was to see how safe the drug was and how …
Phase: PHASE1 • Sponsor: Immunobrain Checkpoint • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC